THE Health Department has confirmed that from 18 Sep the substitution of isosorbide mononitrate tablet 120mg (sustained release) with isosorbide mononitrate tablet 60 mg (sustained release) will be subsidised by the PBS.
The substitution must be in accordance with the Serious Scarcity Substitution Instrument (SSSI) issued by the TGA, with the full list of SSSI-eligible medicines available now at pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Sep 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Sep 21
